DrugPatentWatch Database Preview
Aldesleukin - Biologic Drug Details
Email this page to a colleague
» See Plans and PricingSummary for aldesleukin
| Tradenames: | 1 |
| Patents: | 160 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for aldesleukin |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for aldesleukin |
Recent Clinical Trials for aldesleukin
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Dutch Cancer Society | Phase 1/Phase 2 |
| Radboud University | Phase 1/Phase 2 |
| Intima Bioscience, Inc. | Phase 1/Phase 2 |
Recent Litigation for aldesleukin
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Amgen Inc. v. Accord Healthcare, Inc. | 2018-06-28 |
| Abbott Laboratories v. Watson Laboratories Inc. - Florida | 2010-01-22 |
See all aldesleukin litigation
PTAB Litigation
| Petitioner | Date |
|---|---|
| 2012-09-25 |
Pharmacology for aldesleukin
| Ingredient-type | Interleukin-2 |
| Physiological Effect | Increased Lymphocyte Activation Increased Lymphocyte Cell Production |
Patent Text Search: US Patents for aldesleukin
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiron | PROLEUKIN | aldesleukin | VIAL | 103293 | 001 | 1992-05-05 | Start Trial | Delta Pharmaceuticals, Inc. (Durham, NC) | 2012-02-03 | RX | search | |
| Chiron | PROLEUKIN | aldesleukin | VIAL | 103293 | 001 | 1992-05-05 | Start Trial | Coraje, Inc. (San Francisco, CA) | 2039-02-26 | RX | search | |
| Chiron | PROLEUKIN | aldesleukin | VIAL | 103293 | 001 | 1992-05-05 | Start Trial | SciClone Pharmaceuticals, Inc. (San Mateo, CA) | 2039-02-26 | RX | search | |
| Chiron | PROLEUKIN | aldesleukin | VIAL | 103293 | 001 | 1992-05-05 | Start Trial | Merck & Co., Inc. (Rahway, NJ) | 2020-01-28 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for aldesleukin
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2439933 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2008081910 | Start Trial |
| Japan | 2012519730 | Start Trial |
| Peru | 20080835 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
